X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC PHARMA with Wockhardt - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs WOCKHARDT LTD. - Comparison Results

WOCKHARDT LTD. 
   Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA WOCKHARDT LTD. ALEMBIC PHARMA/
WOCKHARDT LTD.
 
P/E (TTM) x 26.0 16.9 153.9% View Chart
P/BV x 5.9 1.7 344.3% View Chart
Dividend Yield % 0.8 0.0 -  

Financials

 ALEMBIC PHARMA   WOCKHARDT LTD.
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-16
WOCKHARDT LTD.
Mar-16
ALEMBIC PHARMA/
WOCKHARDT LTD.
5-Yr Chart
Click to enlarge
High Rs7922,000 39.6%   
Low Rs443706 62.8%   
Sales per share (Unadj.) Rs167.0403.7 41.4%  
Earnings per share (Unadj.) Rs38.229.5 129.5%  
Cash flow per share (Unadj.) Rs42.042.4 99.1%  
Dividends per share (Unadj.) Rs4.000-  
Dividend yield (eoy) %0.60-  
Book value per share (Unadj.) Rs84.9323.4 26.3%  
Shares outstanding (eoy) m188.52110.51 170.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.73.4 110.3%   
Avg P/E ratio x16.245.9 35.2%  
P/CF ratio (eoy) x14.731.9 46.0%  
Price / Book Value ratio x7.34.2 173.8%  
Dividend payout %10.50-   
Avg Mkt Cap Rs m116,383149,509 77.8%   
No. of employees `000NA7.4 0.0%   
Total wages/salary Rs m4,2149,443 44.6%   
Avg. sales/employee Rs ThNM6,048.6-  
Avg. wages/employee Rs ThNM1,280.2-  
Avg. net profit/employee Rs ThNM441.5-  
INCOME DATA
Net Sales Rs m31,48744,614 70.6%  
Other income Rs m55970 5.7%   
Total revenues Rs m31,54245,584 69.2%   
Gross profit Rs m10,0605,038 199.7%  
Depreciation Rs m7221,426 50.7%   
Interest Rs m371,012 3.6%   
Profit before tax Rs m9,3563,570 262.1%   
Minority Interest Rs m0-65 0.0%   
Prior Period Items Rs m-26 -23.4%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,160255 847.8%   
Profit after tax Rs m7,1943,257 220.9%  
Gross profit margin %31.911.3 282.9%  
Effective tax rate %23.17.1 323.5%   
Net profit margin %22.87.3 313.0%  
BALANCE SHEET DATA
Current assets Rs m15,06639,906 37.8%   
Current liabilities Rs m7,67418,423 41.7%   
Net working cap to sales %23.548.2 48.8%  
Current ratio x2.02.2 90.6%  
Inventory Days Days6790 74.3%  
Debtors Days Days4198 41.4%  
Net fixed assets Rs m8,23735,832 23.0%   
Share capital Rs m377553 68.2%   
"Free" reserves Rs m15,41630,370 50.8%   
Net worth Rs m16,00535,739 44.8%   
Long term debt Rs m016,542 0.0%   
Total assets Rs m24,59479,522 30.9%  
Interest coverage x255.24.5 5,637.6%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x1.30.6 228.2%   
Return on assets %29.45.4 547.7%  
Return on equity %44.99.1 493.3%  
Return on capital %58.78.7 678.1%  
Exports to sales %55.711.6 480.4%   
Imports to sales %10.44.5 233.7%   
Exports (fob) Rs m17,5515,177 339.0%   
Imports (cif) Rs m3,2831,990 165.0%   
Fx inflow Rs m17,8117,589 234.7%   
Fx outflow Rs m5,3182,878 184.8%   
Net fx Rs m12,4934,711 265.2%   
CASH FLOW
From Operations Rs m9,304716 1,299.2%  
From Investments Rs m-3,105-8,182 37.9%  
From Financial Activity Rs m-1,9592,543 -77.1%  
Net Cashflow Rs m4,240-4,923 -86.1%  

Share Holding

Indian Promoters % 74.1 74.5 99.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.9 2.3 126.1%  
FIIs % 9.1 7.7 118.2%  
ADR/GDR % 0.0 0.1 -  
Free float % 13.9 15.4 90.3%  
Shareholders   49,328 67,757 72.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   ABBOTT INDIA  JUBILANT LIFE SCIENCES  DIVIS LABORATORIES  PFIZER  ALKEM LABORATORIES  

Compare ALEMBIC PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Strong Note; Bank & Realty Stocks Rally(Closing)

Indian share markets surged further in the afternoon session and finished in the green for the second straight session on heavy buying in realty stocks, metal stocks and bank stocks.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Aug 23, 2017 03:36 PM

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA 5-YR ANALYSIS

COMPARE ALEMBIC PHARMA WITH

MARKET STATS